16 October 2019 - House Democratic leaders are adjusting their signature bill to lower drug prices in an effort to address progressive concerns that a previous version of it was not strong enough.

The underlying bill will allow the Secretary of Health and Human Services to negotiate lower prices for up to 250 drugs per year, and the savings will apply to people in private insurance plans as well as Medicare.

The changes released Wednesday by the House Energy and Commerce Committee would increase the minimum number of drugs that must be negotiated from 25 to 35, and would require negotiation on some newly-launched drugs if their prices are more than the median U.S. household income.

Read The Hill article